Strategic Partnerships Position Revelar's breath-based biomarker platform as a collaboration-ready solution for hospitals, clinics, and telehealth providers. Emphasize workflow integration, clinician-led pilots, and demonstrated impact on prevention and personalized treatment to accelerate adoption in mid-size health systems.

Regulatory Readiness Highlight the company’s path toward regulatory validation and clinical-grade evidence to reduce buyer risk. Offer assistance with real-world pilot studies, regulatory mapping, and third-party validation to accelerate procurement cycles with health networks and medical device distributors.

Data and Integration Capitalize on the data generated by breath biomarkers by proposing seamless data integration with EHR/EMR systems, secure cloud storage, and intuitive dashboards. Target health IT buyers and value-based care programs that seek continuous measurement of patient risk and treatment response.

Nimble Market Entry Leverage Revelar's small, agile team to deliver rapid pilots and customized biomarker panels for niche indications. Use this to secure early adopters within specialty clinics and regional health networks, then scale through channel partners and distributors.

Competitive Differentiation Differentiate on clinically meaningful outcomes, faster time-to-value, and longevity-focused health insights. Market the breath biomarkers as accessible, noninvasive tests that enable preventive care, align with current market trends toward precision health, and differentiate from larger incumbents by speed and customization.